BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 15578407)

  • 1. Are antimicrobial-impregnated catheters effective? Replace the water and grab your washcloth, because we have a baby to wash.
    McConnell SA; Gubbins PO; Anaissie EJ
    Clin Infect Dis; 2004 Dec; 39(12):1829-33. PubMed ID: 15578407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do antimicrobial-impregnated central venous catheters prevent catheter-related bloodstream infection?
    McConnell SA; Gubbins PO; Anaissie EJ
    Clin Infect Dis; 2003 Jul; 37(1):65-72. PubMed ID: 12830410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rifampicin-impregnated central venous catheters: a meta-analysis of randomized controlled trials.
    Falagas ME; Fragoulis K; Bliziotis IA; Chatzinikolaou I
    J Antimicrob Chemother; 2007 Mar; 59(3):359-69. PubMed ID: 17255143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are antimicrobial-impregnated catheters effective? Don't throw out the baby with the bathwater.
    Crnich CJ; Maki DG
    Clin Infect Dis; 2004 May; 38(9):1287-92. PubMed ID: 15127342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Central venous catheterization: a prospective, randomized, double-blind study.
    Mer M; Duse AG; Galpin JS; Richards GA
    Clin Appl Thromb Hemost; 2009 Feb; 15(1):19-26. PubMed ID: 18593746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The promise of novel technology for the prevention of intravascular device-related bloodstream infection. I. Pathogenesis and short-term devices.
    Crnich CJ; Maki DG
    Clin Infect Dis; 2002 May; 34(9):1232-42. PubMed ID: 11941550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New choices for central venous catheters: potential financial implications.
    Shorr AF; Humphreys CW; Helman DL
    Chest; 2003 Jul; 124(1):275-84. PubMed ID: 12853534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of central venous catheter type and methods on catheter-related colonization and bacteraemia.
    Moretti EW; Ofstead CL; Kristy RM; Wetzler HP
    J Hosp Infect; 2005 Oct; 61(2):139-45. PubMed ID: 16026898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Types of urethral catheters for management of short-term voiding problems in hospitalized adults: a short version Cochrane review.
    Schumm K; Lam TB
    Neurourol Urodyn; 2008; 27(8):738-46. PubMed ID: 18951451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central venous catheter-related bloodstream infections: improving post-insertion catheter care.
    Shapey IM; Foster MA; Whitehouse T; Jumaa P; Bion JF
    J Hosp Infect; 2009 Feb; 71(2):117-22. PubMed ID: 19013680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recommendations and reports about central venous catheter-related infection.
    Bacuzzi A; Cecchin A; Del Bosco A; Cantone G; Cuffari S
    Surg Infect (Larchmt); 2006; 7 Suppl 2():S65-7. PubMed ID: 16895510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic anticoagulant prophylaxis for central catheter-associated venous thrombosis in cancer patients.
    Chan A; Iannucci A; Dager WE
    Ann Pharmacother; 2007 Apr; 41(4):635-41. PubMed ID: 17355999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multilumen central venous catheters increase risk for catheter-related bloodstream infection: prospective surveillance study.
    Templeton A; Schlegel M; Fleisch F; Rettenmund G; Schöbi B; Henz S; Eich G
    Infection; 2008 Aug; 36(4):322-7. PubMed ID: 18663408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective, randomized trial of rifampicin-minocycline-coated and silver-platinum-carbon-impregnated central venous catheters.
    Fraenkel D; Rickard C; Thomas P; Faoagali J; George N; Ware R
    Crit Care Med; 2006 Mar; 34(3):668-75. PubMed ID: 16505651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fusidic acid and heparin lock solution for the prevention of catheter-related bloodstream infections in critically ill neonates: a retrospective study and a prospective, randomized trial.
    Filippi L; Pezzati M; Di Amario S; Poggi C; Pecile P
    Pediatr Crit Care Med; 2007 Nov; 8(6):556-62. PubMed ID: 17914310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central venous catheter replacement in the ICU: new site versus guidewire exchange.
    Castelli GP; Pognani C; Stuani A; Cita M; Paladini R
    Minerva Anestesiol; 2007 May; 73(5):267-73. PubMed ID: 17159763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Microbiological findings in children with an indwelling central venous catheter].
    Uher M; Pisarcíková M; Kurák M; Cernáková A; Takácová V; Molokácová M
    Klin Mikrobiol Infekc Lek; 2004 Dec; 10(6):259-64. PubMed ID: 15655722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A vancomycin-heparin lock solution for prevention of nosocomial bloodstream infection in critically ill neonates with peripherally inserted central venous catheters: a prospective, randomized trial.
    Garland JS; Alex CP; Henrickson KJ; McAuliffe TL; Maki DG
    Pediatrics; 2005 Aug; 116(2):e198-205. PubMed ID: 15995005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Graft or CVC? A prosthetic graft is the better choice].
    Cifarelli M
    G Ital Nefrol; 2009; 26(2):148-53. PubMed ID: 19382069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double-lumen central venous catheters impregnated with chlorhexidine and silver sulfadiazine to prevent catheter colonisation in the intensive care unit setting: a prospective randomised study.
    Camargo LF; Marra AR; Büchele GL; Sogayar AM; Cal RG; de Sousa JM; Silva E; Knobel E; Edmond MB
    J Hosp Infect; 2009 Jul; 72(3):227-33. PubMed ID: 19443078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.